https://omnihealthpractice.com/article/62628ea0cb085817f861062b
Omnihealth Practice | Novel ASCVD risk prediction models for CKD patients: the CRIC study
Omnihealth Practice serves as one medical multichannel provider featuring the latest and trusted information for the industry. We circulate to thousands...
https://lpaforum.org/elevated-lpa-adds-to-healthcare-burden-in-patients-with-ascvd/
Elevated Lp(a) adds to healthcare burden in patients with ASCVD - Lp(a) Forum
Jan 7, 2026 - People with elevated Lp(a) levels and previous atherosclerotic cardiovascular disease (ASCVD) use more healthcare resources, with greater costs and higher
https://cris.bgu.ac.il/en/publications/a-novel-machine-learning-model-for-prediction-of-short-term-ascvd-2/
A novel, machine-learning model for prediction of short-term ASCVD risk over 90 and 365 days -...
https://mail.fortunejournals.com/articles/treat-to-target-ascvd-risk-with-oral-nonstatins-and-bempedoic-acid-delphi-statement.html
Treat to Target ASCVD Risk with Oral Non-statins and Bempedoic Acid: DELPHI Statement
Treat to Target ASCVD Risk with Oral Non-statins and Bempedoic Acid: DELPHI Statement. Open Access Research Article.
https://scholars.aku.edu/en/publications/very-high-risk-ascvd-and-eligibility-for-nonstatin-therapies-base/
Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol...
https://myendoconsult.com/learn/ascvd-calculator/
ASCVD 10-Year Risk Calculator
ascvdyearriskcalculator
https://ascvd-lipidology.knowledgehub.wiley.com/consistency-of-benefit-of-icosapent-ethyl-by-background-statin-type-in-reduce-it/
Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-IT - ASCVD &...
https://pro.novonordisk.ae/scientific-hub/congresses/esc-2025_old/unravelling-cardiovascular-inflammation-in-ascvd.html
Unravelling cardiovascular inflammation in ASCVD: From evidence to guidance
Unravelling cardiovascular inflammation in ASCVD: From evidence to guidance
unravellingcardiovascularinflammationascvdevidence
https://neura.health/glossaries/supplements/statin
Statin for Cholesterol and Heart Risk: LDL Lowering, ASCVD Prevention, Daily Dosing | Neura...
Statins are prescription drugs that lower LDL cholesterol and reduce cardiovascular risk. Use only under clinician guidance with labs and symptom tracking....
https://ascvd-lipidology.knowledgehub.wiley.com/zerlasiran/
Zerlasiran - ASCVD & Lipidology Knowledge Hub
ascvdlipidologyknowledgehub
https://huvolve.com/blog/ascvd-heart-risk-guide/
Your 10-Year Heart Attack Risk: Making Sense of Your ASCVD Score - Huvolve Blog | Huvolve
The ASCVD score is one of the most used calculations in clinical medicine. Your doctor runs it every physical. Here is what it means and what to do with it.
https://ascvd-lipidology.knowledgehub.wiley.com/genetic-testing-in-dyslipidemia-a-scientific-statement-from-the-national-lipid-association/
Genetic Testing in Dyslipidemia. A Scientific Statement from the National Lipid Association - ASCVD...
Jul 31, 2024 - The genetic basis for more than 2 dozen monogenic dyslipidemias has largely been defined. Genetic technologies, such as DNA sequencing, can detect both rare...
https://ascvd-lipidology.knowledgehub.wiley.com/safety-of-the-pcsk9-inhibitor-alirocumab-insights-from-47296-patient-years-of-observation/
Safety Of The Pcsk9 Inhibitor Alirocumab: insights From 47,296 Patient-Years Of Observation - ASCVD...